Russia authorises Sputnik Light COVID vaccine for use -RDIF
- Country:
- Russian Federation
Russia has authorized the one-shot Sputnik Light version of its COVID-19 vaccine for use, the Russian Direct Investment Fund (RDIF) said on Thursday, a move that could help vaccine supplies go further in countries with high infection rates.
Developed by Moscow's Gamaleya Institute, the slimmed-down vaccine, which the RDIF said is 79.4% effective against COVID-19 and costs under $10 a dose, has been earmarked for export and could increase the number of people with partial immunity.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
- READ MORE ON:
- Russia
- Nick Macfie
- Moscow
- Russian Direct Investment Fund
- RDIF
- Gamaleya Institute
Advertisement
ALSO READ
Japan to expand Russia-bound export ban to li-ion batteries, industrial items
Russian forces enter suburb of Chasiv Yar in Ukraine, says RIA
Russia calls Swedish plans for NATO base in Baltic a provocation - RIA
Russia says it downed 53 Ukrainian drones overnight, RIA reports
Russia renews big attacks on Ukrainian power grid using better intelligence and new tactics